“…The HatcheWaxman act could thus be seen as an "inflection point in [the generic drug industry's] growth curve," rather than as the genesis of the generic drug industry itself. 5 But such an account of the production of generic drugs, Greene continues, only tells us part of the story. The circulation and use of such drugs was shaped by an evolving cast of characters and professionsdthe brand-name pharmaceutical industry, the pharmacy and medical professions, congress, and academicians mobilized to both sides of the debate.…”